~~<i id='04F3702839'><strike id='04F3702839'><tt id='04F3702839'><pre id='04F3702839'></pre></tt></strike></i>~~

Home» explore» hotspot

hotspot

author：Wikipedia 2025-09-30 21:06:05 Page View：9

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Why the quest to eradicate polio has stumbled
Next article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

explore

Affirmative action in medical school literally saved lives

AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

AlexHogan/STATPearTherapeuticsmaybegone,butoneofitsmostimportantdealsisstilldrivingcriticalconversat

Medicare details structure of new drug price negotiation program

MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

Pregnancy ages women, but effects reverse after delivery

AdobePregnancyisaknownstressoronthebody.ButanewstudypublishedonFridayinCellMetabolismfoundthatwhilep